Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
albuterol aerosol by HFA MDI
Teva Pharma GmbH
Exercise-induced Bronchospasm
1 trial -
amifampridine phosphate
CATALYST PHARMACEUTICALS, INC.
Myasthenic Syndromes, Congenital
1 trial -
asparaginase
Children's Hospital of Fudan University
Leukemia
2 trials -
asparaginase
United Therapeutics Europe Ltd
Lymphoma
1 trial -
avatrombopag
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Thrombocytopenia
1 trial -
behavior intervention and male circumcision
Xiyuan Hospital of China Academy of Chinese Medical Sciences
HIV
1 trial -
bempedoic acid
Esperion Therapeutics
Hypercholesterolemia
5 trials -
betamethasone
Ultragenyx UK Limited
Respiratory Distress Syndrome
1 trial -
bevacizumab
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Disease Free Survival
1 trial -
bimekizumab
Lacuna Pharma Pty Ltd
Axial Spondyloarthritis
1 trial -
bimekizumab
Lacuna Pharma Pty Ltd
Active juvenile idiopathic arthritis subtypes enthesitis-related arthritis (including juvenile-onset ankylosing spondylitis) and juvenile psoriatic arthritis
1 trial -
biphasic insulin aspart
Novo Nordisk A/S
Diabetes
1 trial -
bupivacaine liposome injectable suspension
Pacira Ireland Limited
Pain, Postoperative
1 trial -
bupivacaine liposome injectable suspension
Pacira Ireland Limited
Knee Osteoarthritis
1 trial -
bupivacaine liposome injectable suspension
Pacira Ireland Limited
Pain
2 trials -
cART(TDF/AZT+3TC+LPV/r)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute HIV Infection
1 trial -
cetuximab + cisplatin + vinorelbine
Merck KGaA, Darmstadt, Germany
Non Small Cell Lung Cancer (NSCLC)
1 trial -
chemotherapy and SHR-1316(Adebrelimab) comnined with surgery or radiotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Limited Stage Small Cell Lung Cancer
1 trial -
ciclesonide (XRP1526)
Takeda
Respiratory Tract Diseases
1 trial -
cilostazol
Hospital Authority, Hong Kong
Coronary Artery Stenosis
1 trial -
cisplatin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Oral Cavity
1 trial -
cisplatin
United Therapeutics Europe Ltd
Bladder Cancer
1 trial -
cisplatin
Pari Pharma GmbH
Lung Cancer
1 trial -
cisplatin i.p.
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Epithelial Carcinoma, Ovarian
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources